| Market Capitalization (Millions $) |
1,915 |
| Shares
Outstanding (Millions) |
456 |
| Employees |
216 |
| Revenues (TTM) (Millions $) |
17,859 |
| Net Income (TTM) (Millions $) |
-3,672 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
508 |
Business Description
Universe Pharmaceuticals Inc is a publicly-traded biopharmaceutical company that is focused on developing and commercializing innovative therapies for the treatment of various cancers and other serious diseases. The company was founded in 2008 and is headquartered in San Francisco, California.
The company's pipeline consists of several drug candidates that are in various stages of clinical development, including both small molecules and biologics. One of the company's most promising candidates is UNI-119, a small molecule inhibitor of a key signaling pathway that is overactivated in many types of cancer. Preclinical studies have shown that UNI-119 is highly effective against a wide range of cancer cells, and the drug is now in phase 1 clinical trials in patients with advanced solid tumors.
In addition to its work on cancer therapeutics, Universe Pharmaceuticals is also actively engaged in research and development in other areas of medicine. The company has recently announced efforts to expand its portfolio to include treatments for neurological disorders, such as Alzheimer's disease and Parkinson's disease.
The company has a strong focus on research and development and has invested considerable resources in building a state-of-the-art research facility to support its drug development efforts. The facility is staffed by an experienced team of scientists and clinicians who are dedicated to developing groundbreaking new therapies for some of the most challenging diseases facing patients today.
In terms of financials, Universe Pharmaceuticals has a market capitalization of over $1 billion and has achieved steady revenue growth over the last several years. The company's strong financial position has allowed it to continue making significant investments in its R&D efforts and has positioned it well to capitalize on its promising pipeline of drug candidates.
In summary, Universe Pharmaceuticals Inc is an innovative biopharmaceutical company focused on developing and commercializing novel therapies for cancer and other serious diseases. With a promising pipeline of drug candidates, a strong focus on R&D, and a commitment to improving patient outcomes, the company is well-positioned for continued growth and success in the industry.
Company Address: 265 Jingjiu Avenue, Ji’an, Jiangxi 343100
Company Phone Number: 86-0796-8403309 Stock Exchange / Ticker: NASDAQ UPC
|
1.97%